NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (Biomechanical Adaptations)
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT06269367
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- NewGait — OTHERwearable limb orthotic device
- Control wearable limb orthotic device — OTHERwearable limb orthotic device
Study Details
An affordable and easy to use gait-assistive device for stroke survivors to use at home is yet to be developed. This study is intended to modify the current design of the NewGait device to specifically work for stroke survivors based on feedback from patients and clinicians. Consequently, conducting a short-term biomechanical gait study is planned to determine the usability and functionality of the NewGait device compared to other comparative devices.
Key Dates
- Start date
- Apr 1, 2024
- Status verified
- Dec 2025
- Primary completion
- Dec 9, 2024
- Completion
- Dec 9, 2024
Study Design
- Enrollment
- 20 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: NewGaitParticipants will put on the NewGait device and walk on the treadmill and overground. Participants may receive biofeedback of their gait patterns to engage them in the training.
- Other: ControlParticipants will put on the Control device and walk on the treadmill and over ground. Participants may receive biofeedback of their gait patterns to engage them in the training.
Primary Outcome Measure
Gait Speed [ Time Frame: Up to 2 hours ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Physical Medicine & Rehabilitation 325 E Eisenhower Pkwy Suite 3011 | Ann Arbor | Michigan | 48108 | - |
Find similar trials in Ann Arbor, MI
By condition
By specialty
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)PHASE2/PHASE3 · Recruiting · DiaMedica Therapeutics Inc · Fairhope, Alabama